Commercializing Innovation: Russ Wilcox '89, MBA '95
Science-based Startups: The Agony and the Ecstasy
Learn more about technology commercialization and enjoy pizza while networking with other Harvard innovators. As part of our ongoing series, renowned entrepreneur Russ Wilcox will share insights from his experience founding E Ink and taking the company to a successful exit, including topics such as company formation, raising money, developing a product, and establishing partnerships.
This event is intended for Harvard graduate students, postdocs, faculty, and staff. Part of the "Commercializing Innovation" speaker series.
Russ Wilcox '89, MBA '95, is an experienced founder and CEO who enjoys helping all kinds of startup companies. He was cofounder and CEO of E Ink and lived the entire venture cycle: seed formation, research, product development, expansion from $0 to $200 million in revenue, and sale of the company. Russ has closed numerous financings, including angel, venture, offshore, and strategic investments; and signed and lived with many kinds of partnerships and alliances. Russ has also worked with startups in software, hardware, science, printing, imaging, robotics, and energy. Most recently, he licensed technology to cofound a biotech startup for drug discovery in immuno-oncology.